# Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain

> **NCT00236327** · PHASE4 · TERMINATED · sponsor: **Janssen Cilag S.A.S.** · enrollment: 34 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** fentanyl

## Key facts

- **NCT ID:** NCT00236327
- **Lead sponsor:** Janssen Cilag S.A.S.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Sponsor discontinued the study following the discovery of a number of incompletely sealed batches that were unusable.
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236327, "Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00236327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*